Functions of nonclassical MHC and non-MHC-encoded class I molecules

Current Opinion in Immunology

Volumn 11, Issue 1, 1999, Pages 100-108

  Braud, Veronique M ^a   Allan, David Sj ^a   McMichael, Andrew J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; GLYCOPROTEIN; HLA ANTIGEN; IRON; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; BACTERIAL INFECTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; INTESTINE EPITHELIUM; IRON METABOLISM; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0033002722     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80018-1     Document Type: Article

References (85)

1. + NK cell clones.
2. + NK cell clones.
3. + NK cell clones. The protection can be reversed by an anti-HLA-E antibody.
4. Braud V, Jones EY, McMichael A The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 27:1997;1164-1169. This paper provides the first identification of peptides binding to HLA-E that derive from the leader sequence of other MHC class I molecules.
5. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol. 160:1998;4951-4960. This study reports the identification of MHC leader peptides bound to HLA-E. Cell surface expression depends on the binding of such peptides in a TAP-dependent manner.
6. Aldrich CJ, Decloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 79:1994;649-658.
7. O'Callaghan CA, Tormo J, Willcox BE, Braud VM, Jakobsen BK, Stuart DI, McMichael AJ, Bell JI, Jones EY Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell. 1:1998;531-541. The analysis of the crystal structure of HLA-E shows that the pockets are all occupied by the side chains of the peptide residues and that the peptide is buried into the groove, partly because of the substitution of the highly conserved tryptophan 147 to a serine in HLA-E.
8. Braud VM, Allan DSJ, Wilson D, McMichael AJ TAP- and tapasin dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol. 8:1998;1-10. This is a demonstration that HLA-E surface expression depends on the binding of MHC class I leader peptides in a TAP- and tapasin-dependent way.
9. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, Lopez-Botet M HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol. 28:1998;2854-2863.
10. Ho EL, Heusel JW, Brown MG, Matsumoto K, Scalzo AA, Yokoyama WM Murine NKg2d and CD94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc Natl Acad Sci USA. 95:1998;6320-6325.
11. Vance RE, Tanamachi DM, Hanke T, Raulet DH Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol. 27:1997;3236-3241.
12. Berg SF, Dissen E, Westgaard IH, Fossum S Two genes in the rat homologous to human NKG2. Eur J Immunol. 28:1998;444-450.
13. Carena I, Shamshiev A, Donda A, Colonna M, De Libero G Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands. J Exp Med. 186:1997;1769-1774.
14. Le Drean E, Vely F, Olcese L, Cambiaggi A, Guia S, Krystal G, Gervois N, Moretta A, Jotereau F, Vivier E Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol. 28:1998;264-276.
15. Ulbrecht M, Modrow S, Srivastava R, Peterson PA, Weiss EH Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. J Immunol. 160:1998;4375-4385.
16. b and, interestingly, the MHC class I leader sequence peptide appears to be dominant.
17. b.
18. b. J Immunol. 158:1997;3244-3251.
19. b binds conserved class I leader peptides derived from several mammalian species. J Exp Med. 188:1998;973-978.
20. Bai A, Forman J The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules. J Immunol. 159:1997;2139-2146.
21. b. Immunity. 9:1998;413-421. This paper suggests that a unique processing pathway for MHC leader sequences exists that does not involve the proteasome.
22. Bouwer HG, Bai A, Forman J, Gregory SH, Wing EJ, Barry RA, Hinrichs DJ Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect Immun. 66:1998;2814-2817.
23. Chun T, Aldrich CJ, Baldeon ME, Kawczynski LV, Soloski MJ, Gaskins HR Constitutive and regulated expression of the class IB molecule Qa-1 in pancreatic beta cells. Immunology. 94:1998;64-71.
24. b. J Exp Med. 188:1998;961-971.
25. + T cells expressing Vβ 8 TCR: a role of the Qa-1 molecule. Immunity. 2:1995;185-194.
26. Jiang H, Kashleva H, Xu LX, Forman J, Flaherty L, Pernis B, Braunstein NS, Chess L T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci USA. 95:1998;4533-4537.
27. Noble A, Zhao ZS, Cantor H Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses. J Immunol. 160:1998;566-571. This paper suggests that Qa-1 is also implicated in immunoregulation.
28. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med. 186:1997;289-298.
29. Schmidt CM, Garrett E, Orr HT Cytotoxic T lymphocyte recognition of HLA-G in mice. Hum Immunol. 55:1997;127-139.
30. Horuzsko A, Antoniou J, Tomlinson P, Portik Dobos V, Mellor AL HLA-G functions as a restriction element and a transplantation antigen in mice. Int Immunol. 9:1997;645-653.
31. Sanders SK, Giblin PA, Kavathas P Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class I molecule on cytotrophoblasts. J Exp Med. 174:1991;737-740.
32. Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS HLA-G1 protein expression is not essential for fetal survival. Placenta. 19:1998;127-132.
33. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE The membrane-bound and soluble forms of HLA-bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity. 3:1995;591-600.
34. Diehl M, Munz C, Keilholz W, Stevanovic S, Holmes N, Loke YW, Rammensee HG Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol. 6:1996;305-314.
35. Schust DJ, Hill AB, Ploegh HL Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J Immunol. 157:1996;3375-3380.
36. Schust DJ, Tortorella D, Seebach J, Phan C, Ploegh HL Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J Exp Med. 188:1998;497-503.
37. Verma S, King A, Loke YW Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol. 27:1997;979-983.
38. Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol. 27:1997;1875-1880.
39. Perez Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, Colonna M, Geraghty DE, Lopez Botet M The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol. 158:1997;5736-5743.
40. Soderstrom K, Corliss B, Lanier LL, Phillips JH CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol. 159:1997;1072-1075.
41. Pazmany L, Mandelboim O, Valez-Gomez M, Davis DM, Reyburn HT, Strominger JL Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science. 274:1996;792-795.
42. Mandelboim O, Pazmany L, Davis DM, Vales-Gomez M, Reyburn HT, Rybalov B, Strominger JL Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA. 94:1997;14666-14670.
43. Munz C, Holmes N, King A, Loke YW, Colonna M, Schild H, Rammensee H Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med. 185:1997;385-391.
44. Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson MS, Moretta L, Biassoni R p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 28:1998;1980-1990.
45. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:1998;3096-3100.
46. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez Botet M A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809-1818.
47. Wang CR, Castano AR, Peterson PA, Slaughter C, Lindahl KF, Deisenhofer J Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell. 82:1995;655-664.
48. Gulden PH, Fischer P III, Sherman NE, Wang W, Engelhard VH, Shabanowitz J, Hunt DF, Pamer EG A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity. 5:1996;73-79.
49. Lenz LL, Dere B, Bevan MJ Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity. 5:1996;63-72.
50. Princiotta MF, Lenz LL, Bevan MJ, Staerz UD H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med. 187:1998;1711-1719.
51. Nataraj C, Brown ML, Poston RM, Shawar SM, Rich RR, Lindahl KF, Kurlander RJ H2-M3wt-restricted, Listeria monocytogenes-specific CD8 T cells recognize a novel, hydrophobic, protease-resistant, periodate-sensitive antigen. Int Immunol. 8:1996;367-378.
52. Nataraj C, Huffman GR, Kurlander RJ H2M3wt-restricted, Listeria monocytogenes-immune CD8 T cells respond to multiple formylated peptides and to a variety of gram-positive and gram-negative bacteria. Int Immunol. 10:1998;7-15. This paper examines the specificty of H2-M3-restricted CTLs and shows that they can respond to a variety of bacterial antigens.
53. Mizuki N, Ota M, Kimura M, Ohno S, Ando H, Katsuyama Y, Yamazaki M, Watanabe K, Goto K, Nakamura Set al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci USA. 94:1997;1298-1303.
54. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA. 93:1996;12445-12450.
55. + γδ T cells from the intestinal epithelium that are restricted by MICA and MICB.
56. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 93:1998;111-123. This paper describes the crystal structure of HFE; the paper shows that the binding groove cannot accommodate peptides or smaller molecules and that the mutations associated with hemochromatosis are likely to disrupt the folding of the molecule. A very interesting characterization of the interaction of HFE with the transferrin receptor follows; it shows that the affinity is very high at pH 7.5 but not at pH 6, consistent with a dissociation in the endosomes after endocytosis.
57. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr., Ellis MC, Fullan Aet al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 13:1996;399-408.
58. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CEet al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA. 95:1998;2492-2497. This paper confirms that lack of a functional HFE leads to disease.
59. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, Fleming RE, Sly WS Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA. 94:1997;13198-13202. This is the first study to report that HFE associates with the transferrin receptor.
60. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA. 95:1998;1472-1477. This work demonstrates that the mutation C282Y prevents HFE from binding to the transferrin receptor whereas the mutation H63D has no such effect; however, while wild-type HFE decreases the affinity of the transferrin receptor for transferrin, H63D HFE does not. It therefore shows that the two mutations in HFE affect its function at two different levels.
61. Gross CN, Irrinki A, Feder JN, Enns CA Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem. 273:1998;22068-22074.
62. Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, Bacon BR, Sly WS Immunohistochemistry of HLA H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA. 94:1997;2534-2539.
63. Bastin JM, Jones M, O'Callaghan CA, Schimanski L, Mason DY, Townsend ARM: Kupper cell staining by an HFE specific monoclonal antibody-implications for hereditary haemochromatosis. Br J Haematol 1998, in press.
64. Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila Set al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem. 272:1997;14025-14028. This paper describes the lack of trafficking of the mutated HFE (C282Y), due to a lack of association with β2 microglobulin.
65. Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN, Schatzman RC, Britton RS, Bacon BR, Sly WS Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA. 94:1997;12384-12389. This paper describes the lack of trafficking of the mutated HFE (C282Y), due to a lack of association with β2 microglobulin.
66. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature. 372:1994;691-694.
67. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJet al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 269:1995;227-230.
68. Beckman EM, Melian A, Behar SM, Sieling PA, Chatterjee D, Furlong ST, Matsumoto R, Rosat JP, Modlin RL, Porcelli SA CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol. 157:1996;2795-2803.
69. Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S, Reinhold VN, Sieling PA, Modlin RLet al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science. 278:1997;283-286. This paper describes the identification of another group of lipid antigens bound to CD1b. It shows that variations in the lipid tails do not significantly affect T cell recognition, suggesting that they are buried in the binding groove of CD1. Variations in the carbohydrate groups, however, affect T cell recognition - consistent with a direct contact with the TCR.
70. Ernst WA, Maher J, Cho S, Niazi KR, Chatterjee D, Moody DB, Besra GS, Watanabe Y, Jensen PE, Porcelli SAet al. Molecular interaction of CD1b with lipoglycan antigens. Immunity. 8:1998;331-340. This reports the characterization of the kinetics of binding of CD1b to lipid antigens. CD1b binds with high affinity and the binding is optimal at acidic pH, consistent with the colocalization of CD1b and lipid antigens in endosomes.
71. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science. 277:1997;339-345. Here, the crystal structure of mouse CD1d reveals a narrower and deeper binding groove which is highly hydrophobic. This is consistent with the binding of lipid antigens.
72. Jackman RM, Stenger S, Lee A, Moody DB, Rogers RA, Niazi KR, Sugita M, Modlin RL, Peters PJ, Porcelli SA The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity. 8:1998;341-351. This paper demonstrates that CD1b is targeted to endosomal compartments by signals present in its cytoplasmic tail. Lipid antigens colocalize in these compartments.
73. Prigozy TI, Sieling PA, Clemens D, Stewart PL, Behar SM, Porcelli SA, Brenner MB, Modlin RL, Kronenberg M The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 6:1997;187-197. This study demonstrates that lipid antigens colocalize with CD1b in endosomal compartments and that the mannose receptor can be involved in this process.
74. + T cells which kill infected macrophages and the bacteria via a granule-dependent mechanism.
75. + NKT cells.
76. Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates Vα14+NK T lymphocytes. J Immunol. 161:1998;3271-3281.
77. Joyce S, Woods AS, Yewdell JW, Bennink JR, De Silva AD, Boesteanu A, Balk SP, Cotter RJ, Brutkiewicz RR Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science. 279:1998;1541-1544. The authors report the identification of glycosylphosphatidylinositol as a major natural ligand of CD1d.
78. + T lymphocytes. Science. 268:1995;863-865.
79. + NKT cells and that early production of IL-4 is impaired as a result of their defective development.
80. + NKT cells and that early production of IL-4 is impaired as a result of their defective development.
81. Exley M, Garcia J, Balk SP, Porcelli S Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells. J Exp Med. 186:1997;109-120.
82. Davodeau F, Peyrat MA, Necker A, Dominici R, Blanchard F, Leget C, Gaschet J, Costa P, Jacques Y, Godard Aet al. Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. J Immunol. 158:1997;5603-5611.
83. Prussin C, Foster B TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol. 159:1997;5862-5870.
84. + NKT cells are crucial in this process.
85. + NKT cells play a role in the regulation of insulin-dependent diabetes mellitus.